Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
A Engström, V Wintzell, M Melbye, H Svanström… - Hepatology, 2024 - journals.lww.com
Association of glucagon-like peptide-1 receptor agonists wit... : Hepatology Association of
glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 …
glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 …
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
A Engström, V Wintzell, M Melbye, H Svanström… - …, 2024 - ingentaconnect.com
Background and Aims: Clinical trials suggest that glucagon-like peptide-1 (GLP-1) receptor
agonists may have beneficial effects on NAFLD, but the impact on hard hepatic end points is …
agonists may have beneficial effects on NAFLD, but the impact on hard hepatic end points is …
[引用][C] Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: a Scandinavian cohort study
JG Yeh, PN Newsome - 2024 - westmid.openrepository.com
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients
with type 2 diabetes: a Scandinavian cohort study Toggle navigation Login Toggle navigation View …
with type 2 diabetes: a Scandinavian cohort study Toggle navigation Login Toggle navigation View …
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A scandinavian cohort study.
A Engström, V Wintzell, M Melbye… - Hepatology …, 2023 - europepmc.org
Association of glucagon-like peptide-1 receptor agonists with serious liver events among
patients with type 2 diabetes: A scandinavian cohort study. - Abstract - Europe PMC Sign in …
patients with type 2 diabetes: A scandinavian cohort study. - Abstract - Europe PMC Sign in …
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
A Engström, V Wintzell, M Melbye… - Hepatology …, 2024 - pubmed.ncbi.nlm.nih.gov
Background and aims Clinical trials suggest that glucagon-like peptide-1 (GLP-1) receptor
agonists may have beneficial effects on NAFLD, but the impact on hard hepatic end points is …
agonists may have beneficial effects on NAFLD, but the impact on hard hepatic end points is …
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
JG Yeh, PN Newsome - Hepatology, 2024 - journals.lww.com
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), first approved by the Food and Drug
Administration for their use in type 2 diabetes in 2005, have gained growing interest in the …
Administration for their use in type 2 diabetes in 2005, have gained growing interest in the …
[引用][C] Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
JG Yeh, PN Newsome - Hepatology (Baltimore, Md.), 2024 - europepmc.org
Association of glucagon-like peptide-1 receptor agonists with serious liver events among
patients with type 2 diabetes: A Scandinavian cohort study. - Abstract - Europe PMC Sign in …
patients with type 2 diabetes: A Scandinavian cohort study. - Abstract - Europe PMC Sign in …
[引用][C] Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
JG Yeh, PN Newsome - Hepatology (Baltimore, Md.), 2024 - pubmed.ncbi.nlm.nih.gov
Association of glucagon-like peptide-1 receptor agonists with serious liver events among
patients with type 2 diabetes: A Scandinavian cohort study Association of glucagon-like …
patients with type 2 diabetes: A Scandinavian cohort study Association of glucagon-like …